72 results
Page 3 of 4
6-K
sgyreq3pr ou
11 Jan 21
Tiziana Life Sciences to participate at J.P. Morgan Healthcare Conference 2021
12:17pm
6-K
EX-99.1
qef13ya2b7zyb5vn9
11 Jan 21
Tiziana Life Sciences to participate at J.P. Morgan Healthcare Conference 2021
12:17pm
6-K
EX-99.1
cknxgbdmrqf1dtwv
12 Nov 20
Report of Foreign Private Issuer
6:04am
6-K
EX-99.1
slh8ht12
30 Sep 20
Interim Results for the Six Months Ended 30 June 2020
6:11am
6-K
EX-99.2
8zxckyar
16 Sep 20
Tiziana Life Sciences Announces Planned Spin Out of StemPrintER into a New Publicly Listed Company, AccuStem Sciences
6:04am
6-K
EX-99.1
orq894 9ex
18 Jun 20
Final Results for the Year Ended 31 December 2019
7:01am
424B5
u9sjbik2 ga
10 Apr 20
Prospectus supplement for primary offering
5:22pm
6-K
890lxwo
1 Apr 20
Current Report of Foreign Issuer
8:57am
6-K
EX-99.1
6xw91fq48n946c
13 Jan 20
Report of Foreign Private Issuer
6:03am
6-K
EX-99.1
20sqp8rbz1xlsq4c8wp
4 Dec 19
Report of Foreign Private Issuer
6:01am
F-1/A
wknhp
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
i83ge9fzq
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
6-K
EX-99.1
c62kjemo8jou c8apa
16 Sep 19
Report of Foreign Private Issuer
7:00am
FWP
8bg xm7dn
5 Aug 19
Free writing prospectus
9:57pm
F-1
6w516h4yam4y
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
xnln z7adyhvplmi7
17 Jul 19
Draft registration statement
12:00am
6-K
EX-99.1
46f8zfa8jjuk6my6m
4 Apr 19
Financial Results for the Year Ended 31 December 2018
6:11am
20-F
2l2d7
4 Apr 19
Annual report (foreign)
6:07am
6-K
EX-99.1
v7c2m
28 Nov 18
A breakthrough approach for treatment of neurodegenerative diseases such as progressive multiple sclerosis
6:01am